In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

At close: December 31 at 4:00:00 PM EST ...

Get the latest news and real-time alerts from PTC Therapeutics, Inc. (PTCT) stock at Seeking Alpha.

Chart does not reflect overnight price.

Live streaming and on-demand. Anywhere and anytime.

First Warn 5 Weather 7-Day Forecast 3 Degree Guarantee First Warn 5 Radar First Warn 5 Weather Show Weather Cams ...